LGND
LGND
NASDAQ · Pharmaceuticals

Ligand Pharmaceuticals

$220.48
-0.93 (-0.42%)
As of May 11, 9:56 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target -85.7% upside
Low Target $18.80
Average Target $31.56
High Target $35.41
Current Price $220.48
Current
$220.48
Target
$31.56
$18.80 $31.56 avg $35.41
Scenario Analysis
Bear Case
$18.80
-91.5%
Low target
Base Case
$31.56
-85.7%
Avg target
Bull Case
$35.41
+-83.9%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$247.38
-10.9% from high
52-Week Low
$98.89
+123.0% from low
50-Day SMA
$193.47
+14.0% vs SMA
200-Day SMA
$162.08
+36.0% vs SMA
RSI (14)
38.7
Neutral
Target vs 52W High
$31.56
-87.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +37.6%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.1%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +31.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +213.5%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +173.7%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -29.8%